Skip to main content
Fig. 7 | Journal of Hematology & Oncology

Fig. 7

From: Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL

Fig. 7

Prediction of clinical relapse based on NGS-detected MRD status post-induction and post-remission CPMRD. a Kaplan-Meier relapse-free survival curves for patients with negative or positive NGS-MRD post induction (between days 30 and 90). b Kaplan-Meier relapse-free survival curves for patients with post remission conversion to positive MRD (CPMRD) or without conversion (NMRDC)

Back to article page